Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes
-
* Corresponding author: Debora Williams-Herman debora_williamsherman@merck.com
BMC Endocrine Disorders 2010, 10:7 doi:10.1186/1472-6823-10-7
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 10 Feb 2010 | |
| Reviewer's Report | Zachary Bloomgarden | 03 Mar 2010 | |
| Reviewer's Report | Guillermo Di Girolamo | 08 Mar 2010 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 29 Mar 2010 |
| Editorial acceptance | 30 Mar 2010 | ||
| Published | 22 Apr 2010 |